RDX and neoplasm: Investigation of the corresponding mechanism (PKCη/Rdx-induced phosphorylation of PDK1 at S135) in human cells and glioma samples has led us to propose PDK1phosphoS135 as a marker of both tumor progression and responsiveness to parvovirus treatment and this pathway, as a potential new target for cancer therapy.